Thomas Tu - 28 Mar 2022 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Medical Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol: N/A
Transactions as of: 28 Mar 2022
Net transactions value: -$180,000
Form type: 4
Filing time: 30 Mar 2022, 16:33:14 UTC
Previous filing: 02 Mar 2022
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$914	+2,000	+2.6%	$0.4570^*	80,274	28 Mar 2022	Direct	F1
transaction	NARI	Common Stock	Sale	$180,000	-2,000	-2.5%	$90.00	78,499	28 Mar 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Option	Options Exercise	$914	-2,000	-0.99%	$0.4570^*	199,584	28 Mar 2022	Common Stock	2,000	$0.4570	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2	Includes 225 shares acquired under the Employee Stock Purchase Plan.
F3	Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.